News

2609, 2017

Confo Therapeutics enters into drug discovery collaboration with Lundbeck

September 26th, 2017|0 Comments

Published on: Sep 26, 2017

2109, 2017

V-Bio Ventures Newsletter sept 2017

September 21st, 2017|0 Comments

Published on: Sep 21, 2017

2508, 2017

Octimet: Dosing of First Patient with investigational agent OMO-1

August 25th, 2017|0 Comments

Published on: Aug 25, 2017

1606, 2017

V-Bio Ventures leads EUR 7.7M financing of Aphea.Bio

June 16th, 2017|0 Comments

Published on: Jun 16, 2017

1901, 2017

V-Bio Ventures invests in OCTIMET Oncology

January 19th, 2017|0 Comments

Published on: Jan 19, 2017

1101, 2017

Oxular Appoints David Fellows as Chairman of the Board

January 11th, 2017|0 Comments

Download this article Oxular Appoints David Fellows as Chairman of the Board • David Fellows appointed as Chairman of Oxular’s Board of Directors • David has more than 30 years of experience in various

112, 2016

V-Bio Ventures closes first life sciences fund, raising over € 75 million

December 1st, 2016|0 Comments

Download this article V-Bio Ventures closes first life sciences fund, raising over € 75 million   Ghent, Belgium, 1 December 2016 – V-Bio Ventures announces the final closing of its V-Bio Ventures Fund 1

609, 2016

Confo Therapeutics appoints Dr. Cedric Ververken as Chief Executive Officer

September 6th, 2016|0 Comments

Download this article Confo Therapeutics appoints Dr. Cedric Ververken as Chief Executive Officer Brussels, September 6, 2016 [09:00 CET] – Confo Therapeutics, an emerging drug discovery company, announces the appointment of Cedric Ververken

1907, 2016

Precision Ocular Ltd Completes £15.5 million Series A Financing V-Bio Ventures joins investment syndicate

July 19th, 2016|0 Comments

Download this article Precision Ocular Ltd Completes £15.5 million Series A Financing   V-Bio Ventures joins investment syndicate     Completes oversubscribed £15.5 million Series A financing round Accelerates development of additional product candidates

1005, 2016

Confo Therapeutics appoints Dr Christel Menet as Chief Scientific Officer

May 10th, 2016|0 Comments

Download this article Confo Therapeutics appoints Dr Christel Menet as Chief Scientific Officer   Brussels, May 10, 2016 [09:00 CET] – Confo Therapeutics, an emerging drug discovery company, announced today that Dr Christel Menet

202, 2016

V-Bio Ventures invests in VIB spinout Confo Therapeutics NV

February 2nd, 2016|0 Comments

Download this article Investment will support first-in-class development programs for pathway selective drugs targeting GPCRs Gent, Tuesday 02 February, 2016 – V-Bio Ventures, an independent Venture Capital Fund, announced today the completion of

1911, 2015

First Closing of V-Bio Ventures Fund 1 with commitments of € 63 million

November 19th, 2015|0 Comments

Download this article Gent, Belgium, 19 November 2015 – V-Bio Ventures announces the first closing of its V-Bio Ventures Fund 1 with € 63 million in capital commitments. V-Bio Ventures will have a close